Life Extension Cognitex® Elite Pregnenolone: The Pharmacist's Guide to Advanced Brain Support

Dai Tran, PharmD, MBA, B.S.

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist

Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience

What Is Life Extension® Cognitex® Elite Pregnenolone?

Cognitex® Elite Pregnenolone is a multi-ingredient cognitive support formula providing eight compounds across several proposed mechanisms: neurosteroid precursor support (pregnenolone), cholinergic membrane support (phosphatidylserine, uridine-5’-monophosphate), adaptogenic stress modulation (Sensoril® ashwagandha), cognitive and attentional support (SIBELIUS™ Sage), antioxidant neuroprotection (wildcrafted blueberry blend), and cerebral blood flow (vinpocetine). This article reviews the published evidence for each ingredient, applies the Clinical Insights three-tier evidence framework, and is explicit about what has not been established for the finished Cognitex® Elite Pregnenolone product. Important safety and regulatory information — including a strong reproductive safety warning — is addressed in detail below.

Supplement Facts (Per 2-Tablet Serving)

Serving size: 2 vegetarian tablets | Servings per container: 30 | Suggested use: Take 2 tablets, preferably early in the day, or as recommended by a healthcare practitioner.

⚠ See regulatory and safety note in the Vinpocetine section below. Gluten-free. Non-GMO LE Certified. Vegetarian tablets. Verify current label before use.

What the Evidence Does — and Does Not — Establish

• SIBELIUS™ Sage (333 mg): The largest ingredient by dose; available sage RCTs show signals for attention and memory in healthy adults and in Alzheimer’s disease populations, though extract composition and standardization vary across studies. SIBELIUS™-specific trial data should be verified for direct comparability.
• Blueberry blend (200 mg): Anthocyanin-rich; positive signals in RCTs for memory in older adults using whole blueberry preparations; formulation comparability with this proprietary 6-species blend is not established.
• Sensoril® Ashwagandha (125 mg): The primary Sensoril® RCT used 600 mg/day in adults with mild cognitive impairment (MCI) — 125 mg in Cognitex® is approximately one-fifth of the studied dose in a different population.
• Phosphatidylserine (100 mg): Key RCTs used 300 mg/day; 100 mg is one-third of the pivotal study dose. FDA qualified health claim applies with the standard “very limited and preliminary” caveat.
• Pregnenolone (50 mg): Neurosteroid precursor with predominantly preclinical evidence for cognitive effects; human RCT evidence in healthy older adults is limited and mixed.
• UMP (50 mg): Preclinical and mechanistic evidence for synaptic support; human cognitive benefit at this dose not established.
• Vinpocetine (20 mg): Studied for cerebral blood flow; subject to an unresolved FDA regulatory status as a dietary supplement ingredient. Strong reproductive safety warning — see section below.
• Not established: That Cognitex® Elite Pregnenolone as a finished product prevents, treats, or reverses cognitive decline or dementia in any population.

Ingredient-by-Ingredient Evidence Review

1. SIBELIUS™ Sage Extract (Salvia officinalis) — 333 mg

SIBELIUS™ Sage is a patented, standardized Salvia officinalis leaf extract standardized to 2.5% rosmarinic acid. Sage has been studied for cognitive effects in healthy adults and in Alzheimer’s disease populations, with proposed mechanisms including acetylcholinesterase inhibition and antioxidant activity.

• HUMAN RCT: A double-blind, placebo-controlled crossover trial (Kennedy DO et al., PMID: 16873125) found that Salvia officinalis extract improved word recall and reduced anxiety in healthy young adults. A separate RCT in Alzheimer’s disease patients (Akhondzadeh S et al., PMID: 12653261) found standardized sage extract improved cognitive function scores versus placebo over 16 weeks. Findings in Alzheimer’s disease populations should not be extrapolated directly to healthy adults.
• Dose and formulation context: The 333-mg amount is within the broad dose range evaluated in Salvia officinalis studies, but extract composition and standardization vary across trials. Findings from other sage preparations should not automatically be transferred to SIBELIUS™ unless extract equivalence is confirmed.
• What this does not establish: That SIBELIUS™ Sage at 333 mg prevents or reverses cognitive decline, or that findings in Alzheimer’s disease populations translate to healthy adults.

2. Proprietary Wildcrafted Blueberry Blend — 200 mg

This proprietary blend draws from six Vaccinium species, providing a broad spectrum of anthocyanins and other polyphenols. Anthocyanins are among the more studied polyphenol classes for cognitive health.

• HUMAN RCT: RCTs using blueberry or anthocyanin-rich berry supplementation in older adults have shown improvements in memory and processing speed (Krikorian R et al., PMID: 20047325; Whyte AR et al., PMID: 28706603). Most trials used whole blueberry powder or juice at higher total anthocyanin doses than a 200-mg proprietary extract blend likely provides.
• What this does not establish: That this specific six-species proprietary blend at 200 mg produces the same cognitive effects as the whole-food blueberry preparations studied in available RCTs, or that it prevents cognitive decline.

3. Sensoril® Ashwagandha (Withania somnifera) — 125 mg

Sensoril® is a clinically studied ashwagandha root and leaf extract standardized to 10% withanolide glycoside conjugates. Ashwagandha has been studied for adaptogenic, anxiolytic, and cognitive effects, primarily in stressed or cognitively impaired populations.

• HUMAN RCT: A randomized, double-blind, placebo-controlled pilot study (Choudhary D et al., PMID: 28471731) evaluated ashwagandha root extract at 300 mg twice daily (600 mg/day) for 8 weeks in 50 adults with mild cognitive impairment (MCI). The treatment group showed improvements in several measures of immediate and general memory, executive function, sustained attention, and information-processing speed versus placebo. Because the study population had MCI, these findings should not be extrapolated directly to cognitively healthy adults.
• Dose context: Cognitex® provides 125 mg/day — approximately one-fifth of the 600-mg/day dose evaluated in this trial. In addition, formulation and extract comparability between the trial preparation and Sensoril® should be confirmed before treating the study as direct evidence for this product’s ashwagandha dose.
• What this does not establish: That 125 mg/day ashwagandha produces the cognitive effects observed in the MCI trial using 600 mg/day, or that findings in an MCI population transfer to healthy adults.

4. Phosphatidylserine (Sharp•PS® GREEN) — 100 mg

PS is a neuronal membrane phospholipid studied for memory and cognitive function in older adults. Sharp•PS® GREEN is a soy-free, sunflower-derived form. The pivotal RCTs used 300 mg/day; 100 mg is one-third of that dose.

• HUMAN RCT: Crook TH et al. (PMID: 1609044) and Cenacchi T et al. (PMID: 8437695) demonstrated PS at 300 mg/day improved memory in older adults with age-associated memory impairment. These findings should not be assumed to apply proportionately to 100 mg.
• FDA qualified health claim: The FDA permits a qualified health claim: “Very limited and preliminary scientific research suggests that phosphatidylserine may reduce the risk of cognitive dysfunction in the elderly.” This is a qualified — not a full — health claim.
• What this does not establish: That 100 mg PS produces cognitive benefits equivalent to the 300 mg/day doses in the pivotal RCTs.

5. Pregnenolone — 50 mg

Pregnenolone is an endogenous neurosteroid precursor synthesized from cholesterol in the adrenal glands and brain, serving as the biosynthetic precursor to DHEA, progesterone, and other steroid hormones. Circulating pregnenolone levels decline with age, though the magnitude and clinical significance vary between individuals.

• PRECLINICAL / MECHANISTIC: Much of the evidence for pregnenolone’s cognitive effects is from animal models showing effects on memory consolidation, NMDA receptor modulation, and GABA-A activity.
• MIXED — HUMAN DATA: Small human studies and trials in schizophrenia have produced mixed results. A well-designed RCT demonstrating cognitive benefit from oral pregnenolone at 50 mg in healthy older adults has not been published.
• Hormonal precursor caution: Pregnenolone is a precursor to DHEA, estrogen, progesterone, testosterone, and cortisol. Supplementation may affect downstream hormone levels unpredictably. Life Extension’s current label advises consulting a healthcare practitioner if at risk for or diagnosed with prostate or breast cancer. This precaution applies to hormone-sensitive conditions more broadly.
• What this does not establish: That oral pregnenolone at 50 mg produces measurable cognitive benefit in healthy older adults, or that supplementing with a precursor is equivalent to endogenous neurosteroid activity.

6. Uridine-5’-Monophosphate, Disodium (UMP) — 50 mg

Uridine is a pyrimidine nucleoside that serves as a precursor to CDP-choline and participates in neuronal membrane phospholipid synthesis. Animal and in-vitro research has demonstrated that uridine, combined with DHA and choline, supports synaptic protein synthesis and dendritic spine density.

• PRECLINICAL / MECHANISTIC: The synaptic support evidence for uridine is largely from animal models (Wurtman RJ et al., PMID: 19609460). Well-powered human RCTs demonstrating cognitive benefit from UMP supplementation alone in healthy adults are limited.
• What this does not establish: That 50 mg UMP/day produces clinically meaningful synaptic or cognitive effects in healthy humans equivalent to those observed in animal models at different doses and combinations.

7. Vinpocetine — 20 mg ⚠ Regulatory & Safety Note

• HUMAN RCT — cerebral blood flow: Vinpocetine has been studied for cerebral blood flow enhancement via phosphodiesterase type 1 (PDE1) inhibition. Small trials have shown increases in cerebral blood flow in older adults and patients with cerebrovascular disease. Large, high-quality RCTs in healthy adults demonstrating meaningful cognitive benefit are limited.
• Antiplatelet activity: Vinpocetine has antiplatelet properties. Use with caution or avoid in patients on anticoagulant or antiplatelet therapy (warfarin, aspirin, clopidogrel); discuss with your pharmacist or prescriber.
• What this does not establish: That vinpocetine at 20 mg produces clinically meaningful cognitive enhancement in healthy adults, or that cerebral blood flow increases observed in small trials translate to improved cognitive outcomes.

Important Safety Considerations

Who May Consider Discussing Cognitex® Elite Pregnenolone?

• Adults over 55 with age-associated cognitive concerns, under pharmacist or physician guidance
• Men or post-menopausal women (not of childbearing age) interested in neurosteroid precursor support, without a history of hormone-sensitive cancer or seizures
• Individuals experiencing cognitive effects of chronic stress who want to discuss adaptogenic support options
• Those seeking a multi-ingredient formula combining several evidence-informed cognitive support mechanisms in one product
• Not appropriate for: Women of childbearing age or anyone who is pregnant or planning pregnancy (FDA advisory and manufacturer label); anyone with a history of seizures (manufacturer label); individuals with prostate or breast cancer risk/history without physician clearance; individuals on anticoagulants without pharmacist review.

Pharmacist’s Note

As a PharmD, I discuss Cognitex® Elite Pregnenolone selectively — primarily with older male patients and post-menopausal women over 55 who have no history of seizures, no hormone-sensitive cancer history, and are not on anticoagulants. The SIBELIUS™ Sage at 333 mg is the highest-dose ingredient and has the most directly applicable human RCT evidence for attention and word recall, though extract comparability across sage studies should be confirmed. The Sensoril® ashwagandha has a relevant RCT in an MCI population at 600 mg/day; the 125-mg dose in Cognitex® is approximately one-fifth of that studied dose in a different population, and I discuss this gap explicitly with patients. Phosphatidylserine at 100 mg is one-third of the 300-mg/day pivotal study dose, but is more meaningfully dosed than in many multi-ingredient cognitive formulas.

I am transparent that pregnenolone’s cognitive evidence is largely preclinical, that the finished product has not been tested as a combination in an independent trial, and that the vinpocetine regulatory status is an unresolved matter I disclose explicitly. The reproductive safety warning for vinpocetine is based on both the FDA advisory and Life Extension’s own current label — I do not discuss this product with patients of childbearing age under any circumstances, and I screen for seizure history before any discussion. Free PharmD consultation: (408) 622-8068.

Do not use if you are of childbearing age, pregnant, or planning to become pregnant. Do not take if you have a history of seizures. Consult your pharmacist before use if you take anticoagulants or have hormone-sensitive conditions or cancer history.

Selected Key Studies

1. HUMAN RCT Kennedy DO, Pace S, Haskell C, et al. Effects of cholinesterase inhibiting sage (Salvia officinalis) on mood, anxiety and performance on a psychological stressor battery. Neuropsychopharmacology. 2006;31(4):845–852. PMID: 16873125.
   Double-blind, placebo-controlled crossover RCT in healthy young adults; Salvia officinalis extract improved word recall and reduced anxiety. Extract composition and standardization should be confirmed for comparability with SIBELIUS™ before treating this as direct evidence for the proprietary extract.
2. HUMAN RCT Choudhary D, Bhattacharyya S, Bose S. Efficacy and Safety of Ashwagandha (Withania somnifera (L.) Dunal) Root Extract in Improving Memory and Cognitive Functions. J Diet Suppl. 2017;14(6):599–612. PMID: 28471731.
   Randomized, double-blind, placebo-controlled pilot study in 50 adults with mild cognitive impairment (MCI); ashwagandha 300 mg twice daily (600 mg/day) for 8 weeks improved memory, executive function, attention, and processing speed. Population had MCI — not cognitively healthy adults. Cognitex® provides 125 mg/day, approximately one-fifth of the studied dose.
3. HUMAN RCT Krikorian R, Shidler MD, Nash TA, et al. Blueberry supplementation improves memory in older adults. J Agric Food Chem. 2010;58(7):3996–4000. PMID: 20047325.
   Pilot RCT; wild blueberry supplementation improved paired associate learning and word list recall in older adults with early memory changes. Whole-food blueberry preparation; comparability with the 200-mg proprietary 6-species extract blend in Cognitex® is not established.
4. HUMAN RCT Crook TH, Tinklenberg J, Yesavage J, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 1991;41(5):644–649. PMID: 1609044.
   Double-blind RCT; PS at 300 mg/day improved memory recall in older adults with age-associated memory impairment. Cognitex® provides 100 mg — one-third of the studied dose; proportionate benefit at this dose is not established.
5. PRECLINICAL / MECHANISTIC Wurtman RJ, Cansev M, Sakamoto T, Ulus IH. Nutritional modifiers of aging brain function: use of uridine and other phosphatide precursors to increase formation of brain synapses. Nutr Rev. 2010;68 Suppl 2:S88–98. PMID: 19609460.
   Animal and mechanistic data; uridine combined with DHA and choline supports synaptic membrane and protein synthesis in rodent models. Human cognitive benefit from UMP supplementation alone at supplement doses in healthy adults is not established.

Reviewed by: Dai Tran, PharmD, MBA, B.S.  View full bio →

CEO & Lead Pharmacist, Khang Pharmacy • CA/MN/TX Licensed Pharmacist

Clinical Insights Series • APhA Immunization Certified • 10+ Years Clinical Experience

Khang Pharmacy | 2451 S King Rd., Ste A1, San Jose, CA 95122 | (408) 622-8068 | www.khangpharmacy.com